Literature DB >> 2679965

Evaluation of non-invasive and invasive methods in the assessment of short saphenous vein termination.

S N Vasdekis1, G H Clarke, J T Hobbs, A N Nicolaides.   

Abstract

Surgery of the short saphenous vein is associated with a high recurrence rate because of variations in the anatomy or inadequate clinical examination. To prevent this, accurate definition of the pattern and level of termination of the saphenopopliteal junction and flush ligation is necessary. Clinical examination, Doppler ultrasound, duplex scanning and peroperative venography have been compared to assess the level of termination of the short saphenous vein. In all, 64 limbs of 46 patients were examined. In 39 limbs there was primary short saphenous incompetence, in 13 limbs there was recurrent short saphenous incompetence; in ten of these there was incompetence of the gastrocnemius vein. In 12 limbs a duplex scan did not demonstrate incompetence of the short saphenous vein or gastrocnemius vein. The accuracy of these methods when locating incompetence of the short saphenous vein to within 2 cm of the saphenopopliteal junction was 56 per cent for clinical examination, 64 per cent for Doppler ultrasound and 96 per cent for duplex scanning. When there was no saphenopopliteal junction (9 per cent), duplex scanning correctly detected the pattern of the incompetent vein. The apparent success of clinical examination was because the vein was not felt above the femoral intercondylar groove and 52 per cent of the veins terminated at this level. Duplex scanning is a non-invasive technique which is almost as accurate as venography and provides additional haemodynamic information about the incompetent veins by demonstrating the presence and extent of reflux.

Entities:  

Mesh:

Year:  1989        PMID: 2679965     DOI: 10.1002/bjs.1800760919

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Is a palpable short saphenous vein a useful clinical sign in varicose vein assessment?

Authors:  S Aiono; M J Simmons; R B Galland; T R Magee
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Colour flow duplex in the assessment of recurrent varicose veins.

Authors:  H S Khaira; A Parnell; M C Crowson
Journal:  Ann R Coll Surg Engl       Date:  1996-03       Impact factor: 1.891

3.  Optimising a varicose vein service to reduce recurrence.

Authors:  E P Turton; S McKenzie; M J Weston; D C Berridge; D J Scott
Journal:  Ann R Coll Surg Engl       Date:  1997-11       Impact factor: 1.891

4.  Duplex scanning may be used selectively in patients with primary varicose veins.

Authors:  P J Kent; M J Weston
Journal:  Ann R Coll Surg Engl       Date:  1998-11       Impact factor: 1.891

5.  Anatomical variation at the sapheno-femoral junction.

Authors:  Kimihiro Igari; Masayuki Hirokawa; Hidetoshi Uchiyama; Takahiro Toyofuku; Toshifumi Kudo; Masatoshi Jibiki; Nobuhisa Kurihara; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2013-11-15

6.  Audit of introduction of hand-held Doppler and duplex ultrasound in the management of varicose veins.

Authors:  H C Pleass; J D Holdsworth
Journal:  Ann R Coll Surg Engl       Date:  1996-11       Impact factor: 1.891

7.  The place of duplex scanning for varicose veins and common venous problems.

Authors:  W B Campbell; A S Halim; A Aertssen; B M Ridler; J F Thompson; P G Niblett
Journal:  Ann R Coll Surg Engl       Date:  1996-11       Impact factor: 1.891

8.  Targeted endovenous treatment of Giacomini vein insufficiency-associated varicose disease: considering the reflux patterns.

Authors:  Mehmet Mahir Atasoy; Burçak Gümüş; Ismail Caymaz; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

9.  Early results of endovenous ablation with a 980-nm diode laser for an incompetent vein of Giacomini.

Authors:  Sang Woo Park; Song Am Lee; Jae Joon Hwang; Ik Jin Yun; Jun Seok Kim; Seong-Hwan Chang; Hyun Keun Chee; Il Soo Chang
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.